Caseware UK (AP4) 2024.0.164 2024.0.164 2024-03-312024-03-31false2023-04-01falsetrueNo description of principal activity22The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 14525060 2023-04-01 2024-03-31 14525060 2022-12-06 2023-03-31 14525060 2024-03-31 14525060 2023-03-31 14525060 c:Director1 2023-04-01 2024-03-31 14525060 d:CurrentFinancialInstruments 2024-03-31 14525060 d:CurrentFinancialInstruments 2023-03-31 14525060 c:Micro-entities 2023-04-01 2024-03-31 14525060 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 14525060 c:FullAccounts 2023-04-01 2024-03-31 14525060 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 14525060 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 14525060









MANGROVE CLINICAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
REGISTERED NUMBER: 14525060

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2024
2023
2023
£
£
£
£


Fixed assets
2,771
-

Current assets
462,542
150,003

Creditors: amounts falling due within one year
(205,895)
(32,534)

Net current assets
 
 
256,647
 
 
117,469

Total assets less current liabilities
259,418
117,469


Net assets
259,418
117,469



Capital and reserves
259,418
117,469

Page 1

 
REGISTERED NUMBER: 14525060
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

Notes


General information

Mangrove Clinical Limited is a private company limited by shares and registered in England and Wales.
The address of its registered office and trading address is 124 Finchley Road, London, England, NW3 5JS.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


Directors' confirmations

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 March 2025.




Joanne M Mcdermid
Director

 
Page 2